期刊文献+

主动脉内球囊反搏治疗对晚期扩张型心肌病患者血浆脑钠尿肽的影响

Effect of intra-aortic balloon pump counterpulsation on serum brain natriuretic peptide in patients with terminal dilated cardiomyopathy
下载PDF
导出
摘要 目的:观察主动脉球囊反搏(intra-aortic balloon pump,IABP)治疗在晚期扩张型心肌病(dilated cardiomyopa-thy,DCM)患者对血浆脑钠尿肽(brain natriuretic peptide,BNP)值变化的影响。方法:晚期DCM患者41例,在最优药物治疗基础上按是否应用IABP分为IABP植入组(植入组,21例),非植入组(对照组,20例)。免疫化学发光法测患者人院后第1、2、7天血浆BNP浓度。结果:入院第1天两组BNP值差异无统计学意义。入院后第2、7天,植入组BNP值明显低于对照组[(1778±289)ng/L vs.(2553±346)ng/L,P<0.05;(835±190)ng/L vs.(1376±301)ng/L,P<0.05]。结论:在最优药物治疗基础上,IABP能进一步降低晚期DCM患者BNP值。 AIM:To evaluate the efficacy and the safety of intra-aortic balloon pump(IABP) counterpulsation and its effect on the concentration of serum brain natriuretic peptide(BNP) in patients with terminal dilated cardiomyopathy(DCM).METHODS: Forty-one patients with DCM complicated by pump failure were divided into IABP group(A: 21 cases) and control group(B: 20 cases) based upon the optimal medication.The plasma concentration of BNP was measured using chemiluminescence immunoassay at 1,2 and 7 days after admission.RESULTS: On the first day of admission,no statistical difference in the values of BNP concentration was observed between groups.On the second and the seventh day of admission,the values of BNP concentration in group A were lower than those in group B(1778±289) pg/ml vs.(2553±346) pg/ml,P0.05;(835±190) pg/ml vs.(1376±301) pg/ml,P0.05).CONCLUSION: In patients with terminal DCM complicated with pump failure,IABP counterpulsation based upon the optimal medication is an effective and safe method to improve cardiac function and lower plasma BNP level.
出处 《心脏杂志》 CAS 2012年第6期726-728,共3页 Chinese Heart Journal
关键词 心肌病 扩张型 主动脉内球囊反搏术 脑钠尿肽 dilated cardiomyopathy intra-aortic balloon pump brain natriuretic peptide
  • 相关文献

参考文献9

二级参考文献16

  • 1DAVIS M, ESPINER E, RICHARDS G, et al. Plasma brain natriuretic peptide in assessment of acute dyspnea[J].Lancet, 1994,343 : 440-- 444.
  • 2CHEN H H, BURNETT J C. Natriuretic peptides in the pathophysiology of congestive heart failure[J].Curr Cardiol Rep, 2000,2 : 198-- 205.
  • 3Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 4Maisel A,Koon J,Krishnaswamy P,et al.Utility of B-natriuretic peptide as a rapid point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction[J].Am Heart J,2001,141:367-374.
  • 5Hirata Y,Matsumoto A,Aigigo T,et al.Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload[J].Cardiovasc Res,2001,51:585-591.
  • 6Groenning BA,Nilsson JC,Sondergaard L,et al.Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations[J].Eur J Heart Fail,2001,3:699-708.
  • 7Liao Y H,Int J Cardiol,1998年,64卷,25页
  • 8Liao Y H,Chin Med J,1996年,109卷,193页
  • 9程龙献,临床心血管病杂志,1995年,11卷,335页
  • 10孙长生 李良寿 李远贵 孙长生.筛检与诊断试验的评价[A].李良寿,李远贵,孙长生.临床医学研究原理与方法[M].西安:陕西科学技术出版社,2000.179-184.

共引文献2171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部